Loading...
Adaptive Mitochondrial Reprogramming and Resistance to PI3K Therapy
BACKGROUND: Small molecule inhibitors of phosphatidylinositol-3 kinase (PI3K) have been developed as molecular therapy for cancer, but their efficacy in the clinic is modest, hampered by resistance mechanisms. METHODS: We studied the effect of PI3K therapy in patient-derived tumor organotypic cultur...
Na minha lista:
| Udgivet i: | J Natl Cancer Inst |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Oxford University Press
2015
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4565533/ https://ncbi.nlm.nih.gov/pubmed/25650317 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jnci/dju502 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|